Related references
Note: Only part of the references are listed.Research criteria for the diagnosis of Alzheimer's disease: genetic risk factors, blood biomarkers and olfactory dysfunction
Jonathan Foster et al.
INTERNATIONAL PSYCHOGERIATRICS (2008)
Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes et al.
LANCET (2008)
General risk factors for dementia: A systematic evidence review
Christopher Patterson et al.
ALZHEIMERS & DEMENTIA (2007)
Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: An age-related selective uptake with reversal of learning impairment
William A. Banks et al.
EXPERIMENTAL NEUROLOGY (2007)
In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques
Joseph F. Poduslo et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Stimulation of endogenous neurogenesis by anti-EFRH immunization in a transgenic mouse model of Alzheimer's disease
Maria Becker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Monoclonal antibodies that target pathological assemblies of A beta
Mary P. Lambert et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics
Leslie M. Shaw et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease
N. M. Kemppainen et al.
NEUROLOGY (2006)
Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease
I. J. Martins et al.
MOLECULAR PSYCHIATRY (2006)
Intravenous immunoglobulin enhances the clearance of fibrillar amyloid-β peptide
Gili Istrin et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Modulation of microglial activation state following passive immunization in amyloid depositing transgenic mice
Dave Morgan
NEUROCHEMISTRY INTERNATIONAL (2006)
Targeting amyloid-β peptide (Aβ) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Aβ precursor protein (APP) transgenic mice
EB Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Antibodies against β-amyloid reduce Aβ oligomers, glycogen synthase kinase-3β activation and τ phosphorylation in vivo and in vitro
QL Ma et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
The F(ab′)2 fragment of an Aβ-specific monoclonal antibody reduces Aβ deposits in the brain
Y Tamura et al.
NEUROBIOLOGY OF DISEASE (2005)
Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease
NC Fox et al.
NEUROLOGY (2005)
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
S Gilman et al.
NEUROLOGY (2005)
Meningoencephalitis associated with passive immunization of a transgenic murine model of Alzheimer's amyloidosis
EB Lee et al.
FEBS LETTERS (2005)
Human monoclonal antibodies against amyloid-beta from healthy adults
V Geylis et al.
NEUROBIOLOGY OF AGING (2005)
HSV amplicon-mediated Aβ vaccination in Tg2576 mice:: differential antigen-specific immune responses
WJ Bowers et al.
NEUROBIOLOGY OF AGING (2005)
Anti-Aβ antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice
RP Brendza et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from β-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide
MG Agadjanyan et al.
JOURNAL OF IMMUNOLOGY (2005)
Aβ vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease
E Masliah et al.
NEUROLOGY (2005)
Prevalence of vitamin D deficiency in Isfahani High School students in 2004
M Moussavi et al.
HORMONE RESEARCH (2005)
Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease
D Frenkel et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Intravenous immunoglobulins containing antibodies against β-amyloid for the treatment of Alzheimer's disease
RC Dodel et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Current concepts and future prospects for Alzheimer disease vaccines
FL Heppner et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2004)
Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease
I Ferrer et al.
BRAIN PATHOLOGY (2004)
Lessons from the AN 1792 Alzheimer vaccine:: lest we forget
SR Robinson et al.
NEUROBIOLOGY OF AGING (2004)
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
JM Orgogozo et al.
NEUROLOGY (2003)
Antibodies against β-amyloid slow cognitive decline in Alzheimer's disease
C Hock et al.
NEURON (2003)
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide:: a case report
JAR Nicoll et al.
NATURE MEDICINE (2003)
Combination therapy of donepezil and vitamin E in Alzheimer disease
ET Klatte et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2003)
Cerebral hemorrhage after passive anti-Aβ immunotherapy
M Pfeifer et al.
SCIENCE (2002)
Therapeutically effective antibodies against amyloid-β peptide target amyloid-β residues 4-10 and inhibit cytotoxicity and fibrillogenesis
J McLaurin et al.
NATURE MEDICINE (2002)
Generation of antibodies specific for β-amyloid by vaccination of patients with Alzheimer disease
C Hock et al.
NATURE MEDICINE (2002)
Passive immunization against β-amyloid peptide protects central nervous system (CNS) neurons from increased vulnerability associated with an Alzheimer's disease-causing mutation
MH Mohajeri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Amyloid β peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier
JF Poduslo et al.
NEUROREPORT (2001)
A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD
B Winblad et al.
NEUROLOGY (2001)
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy
BJ Backskai et al.
NATURE MEDICINE (2001)
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
C Janus et al.
NATURE (2000)
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
D Morgan et al.
NATURE (2000)
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F Bard et al.
NATURE MEDICINE (2000)
Share Paper
